2 reports of this reaction
3.8% of all FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE reports
#2 most reported adverse reaction
LUNG DISORDER is the #2 most commonly reported adverse reaction for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, manufactured by CVS Pharmacy. There are 2 FDA adverse event reports linking FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE to LUNG DISORDER. This represents approximately 3.8% of all 52 adverse event reports for this drug.
Patients taking FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE who experience lung disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LUNG DISORDER is moderately reported among FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE users, representing a notable but not dominant share of adverse events.
In addition to lung disorder, the following adverse reactions have been reported for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE:
The following drugs have also been linked to lung disorder in FDA adverse event reports:
LUNG DISORDER has been reported as an adverse event in 2 FDA reports for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
LUNG DISORDER accounts for approximately 3.8% of all adverse event reports for FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, making it one of the most commonly reported side effect.
If you experience lung disorder while taking FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.